Consolidated Financial Statements for the Second Quarter of FY2025 (Ending March 31, 2026)
GUNZE LIMITED
TSE Prime (Code:3002)
- Financial Statements for the Second Quarter of FY2025
- Business Summary for the Second Quarter of FY2025
- Forecast for FY2025
- Financial Statements for the Second Quarter of FY2025 (Ending March 31, 2026)
Consolidated operating results
(Million of yen)
FY2025 2Q
Bottom Profit Margin
FY2024 2Q
Bottom Profit Margin
Y on Y
Increase
(Decrease)
Change
(%)
Net Sales
65,270
67,329
(2,059)
(3.1)
Operating profit
3,186
4.9%
3,566
5.3%
(379)
(10.7)
Ordinary profit
3,205
4.9%
3,667
5.4%
(462)
(12.6)
Profit attributable to owners of parent
(658)
(1.0%)
2,956
4.4%
(3,615)
-
Apparel Business Restructuring Expenses (3,498)
(Major Extraordinary Loss)
Consolidated operating results
Net sales: Decreased by ¥2,059 million due to the cessation of operations of electronic components at the end of the previous fiscal year and stagnant domestic and international demand for plastic film.
Operating and ordinary profit: Operating profit decreased by ¥379 million and ordinary profit decreased by ¥462 million due to increased fixed costs in the Medical and decreased sales volume and increased costs in the Apparel.
Net loss attributable to owners of parent: Decreased by ¥3,615 million, primarily due to restructuring costs in the apparel business that were recorded in the first quarter.
Full-Year Forecast: The previously announced financial forecast remains unchanged since the results of the current interim consolidated accounting period are generally within the expected range.
Mid-Term Management Plan VISION 2030 Stage 2
To Be “Company of Choice Globally”, Advance Business Foundation.
Reduce costs by utilizing external knowledge
(Build-Up Project)
Business Process
Reform
Business Structure Reform
Apparel Structural Reform
(AX Project)
Efficiency and speed
Improving Corporate Fundamentals
Human capital activation
Rebirth into value-creating business
Corporate Culture Reform
Personnel System Reform
Apparel Structural Reform
FY 2024 to 2027
Operating Profit Improvement Target: ¥3.3 billion
Items
Close domestic production sites
Close domestic
logistics sites
FY2025 FY2026 FY2027
Enhance Gunze's original value while improving cost competitiveness.
Yanase Factory: Closed at
the end of March Tohoku Gunze: Closed at the end of December
Reduce inventory and improve functionality by consolidating logistics hubs and restructuring.
Ayabe: Closed at the
end of December
Fukuchiyama: Closed at the end of December
Voluntary retirement
program
Optimize indirect personnel to transform the business model by
specializing in specific areas.
Voluntary Retirement Program Applicants: 82 applicants. "Next Challenge Program" Support Details:
-Retirement Bonus Payment: An extra added to the standard retirement allowance.
-Reemployment Support Services: In addition to support from public institutions, individuals
Resigned on January 20
Personnel system reform
Develop a talent and organizational culture that can implement management strategies to enhance sustainable corporate value and competitiveness.
The ideal personnel profile | ||
Individuals who understand diversity | Self-reliant individuals | Challenge-driven individuals |
Human resource management policy | ||
Fairness | Convincing | Transparency |
Seniority-based ⇒ Merit-based | Achieving the optimal balance between individual career development and organizational management | Promote open and honest communication |
Human resources initiatives | Our vision (To-be) |
Recruitment | Accepting diverse talent and increasing mid-career hiring to 50%. |
Assignment | Implement systems that enable work arrangements that accommodate work-life balance. |
Development | Self-directed development: - Categorizing and developing employees into management, supervisory, and highly specialized roles. |
Evaluation | Enhanced transparency: Rewarding evaluations of challenging talents and minimizing seniority-based elements. |
Compensation (Grade/Pay) | Job-based system (management roles): Wage structure is aligned with job responsibilities or roles. |
Strengthen the company's competitiveness by attracting self-reliant and proactive individuals who embrace challenges.
Personnel system reform
Build-Up Project
-Reduce costs by utilizing external knowledge-
Purpose | Cost Reduction | Despite rising labor costs and soaring expenses for raw materials and energy, the company will strive to enhance our competitiveness and profitability. |
Corporate restructuring | -Take a fresh look at work methods. -Prioritize speed and external insights. |
Previously: Cost reduction driven by insights from each internal department.
Current Approach: To leverage external expertise, a dedicated organization will be established at headquarters and made available to all employees.
I-5(2). Initiatives to enhance corporate fundamentals
Build-Up Project
-Reduce costs by utilizing external knowledge-
Conduct a comprehensive review to identify all potential cost reduction areas from the ground up.
This includes general expenses, direct material costs, logistics costs, utility
costs, repair costs, auxiliary material costs, administrative personnel costs,
and manufacturing overhead personnel costs.
Pursuit of overall optimization
Fact- and data-driven approach
Thorough cost reduction initiatives.
Boost each employee's responsiveness and strengthen competitiveness.
I-6. Second Quarter Financial Summary
Key Points of Segment Performance (April 1, 2025 to September 30, 2025)
Decrease in sales and increase in profit
Functional Solutions
Medical
Apparel
Lifestyle Creations
Sluggish consumption of plastic films is due to food price hikes and low-price competition in overseas markets.
Engineering plastics products for the office automation sector generally performed well, while those for the semiconductor market were impacted by the downturn in market conditions.
Sales decreased by approximately ¥1.6 billion due to the cessation of operations of electronic components business.
Increase in sales and decrease in profit
Domestic sales of absorbable medical devices, such as anti-adhesion and bone fixation materials, saw steady expansion. However, sales of purchased items, such as medical lasers, faced challenges due to intensifying competition.
Sales in China generally progressed smoothly, focusing on tissue reinforcement materials, but were affected by
costly medical regulations.
In addition to the impact of the weakening yuan on the exchange rate, fixed costs increased due to capital expenditures for business expansion and personnel growth.
Decrease in sales and profit
While retail channels, such as apparel mass retailers, were impacted by unfavorable weather, reduced sales floor space, and consumers' reluctance to purchase clothing, e-commerce channels experienced sales growth, primarily driven by differentiated products, such as ASEDORON and women's underwear.
The company faced increased costs, including higher material and labor expenses, due to reduced production
volumes resulting from inventory reduction efforts as part of its business restructuring.
Increase in sales and profit
The real estate segment performed well, driven by increased visitor traffic due to the renewal of commercial
facilities.
Profitability in the sports club segment improved due to sales recovery at existing stores and reduced unprofitable locations.
Net Sales | Operating Profit Bottom: Profit Margin | |||||
FY2025 N2Q | FY2024 N2Q | YoY | FY2025 N2Q | FY2024 N2Q | YoY | |
Functional Solutions | 23,667 | 25,635 | (7.7%) (1,967) | 3,346 14.2% | 3,251 12.7% | 2.9% 94 |
Medical | 6,480 | 6,468 | 0.2% 12 | 948 14.6% | 1,279 19.8% | (25.8%) (330) |
Apparel | 29,785 | 29,869 | (0.3%) (84) | 249 0.8% | 417 1.4% | (40.3%) (168) |
Lifestyle Creations | 5,838 | 5,737 | 1.8% 101 | 475 8.1% | 303 5.3% | 56.8% 172 |
Total | 65,270 | 67,329 | (3.1%) (2,059) | 3,186 4.9% | 3,566 5.3% | (10.7%) (379) |
Ⅰ-7. FY2025 N2Q Performance by Segment
Consolidated Performance
(millions of yen)
Ⅰ-8. FY2025 N2Q Segment Composition
(Million of yen)
FY2025 2Q
9%
5,838
36%
5%
249
9%
475
23,667
45%
29,785
19%
948
Sales
¥65.2 billion
Operating profit
¥3.1 billion
67%
3,346
Operating Profit
Sales
10%
6,480
Apparel
Medical
(BM: FY2022 2Q)
Lifestyle Creation Functional Solutions
Lifestyle Creation
Functional Solutions
11%
7,172
4%
4% 198
190
37%
68%
44%
24%
1,078
Sales
¥67.3 billion Operating Profit
¥3.5 billion
24,836
30,082
3,114
Operating profit
Sales
8%
5,631
Apparel Medical
Ⅰ-9. Net Sales & Operating Profit for FY2025 2Q
Net Sales 65,270 YoY (3.1%) (Million of yen)
Operating Profit 3,186 YoY (10.7%)
<Sales by Business Segment>
Profit Margin: %
67,350 65,153 67,329
65,270
Functional
3,566
3,230
5.0
3,186
4.2
5.3
198
3,251
3,346
2,937
3,114
907
1,279
948
1,078
775
417
249
475
190
297
303
2,806
4.9
24,836
5,631
24,251
5,492
25,635
6,468
23,667
6,480
Solutions
36%
Medical 10%
Function Solutions 67%
30,082
7,172
29,373
6,428
29,869
5,737
29,785
5,838
Apparel 45%
Life Creation 9%
Medical
19%
Apparel
5%
Life
Creation
15
FY2022 FY2023 FY2024 FY2025
FY2022 FY2023 FY2024 FY2025 9%
Through the sale of electronic components business,
Functional Solutions sales decreased.
Decrease in profit due to increased fixed costs in the medical and a significant impact from reduced apparel profits during restructuring.
I-10. Quarterly Financial Results
(Million of yen)
1Q | 2Q | ||||||||
FY2025 | FY2024 | Increase/Decrease | FY2025 | FY2024 | Increase/Decrease | ||||
Net sales | 32,240 | 33,382 | (1,142) | (3.4) | 33,029 | 33,946 | (917) | (2.7) | |
Functional Solutions | 11,515 | 12,650 | (1,135) | (9.0) | 12,152 | 12,984 | (832) | (6.4) | |
Medical | 3,145 | 3,109 | 35 | 1.1 | 3,335 | 3,358 | (22) | (0.7) | |
Apparel | 14,763 | 14,795 | (31) | (0.2) | 15,021 | 15,074 | (52) | (0.3) | |
Life Creation | 3,018 | 3,024 | (5) | (0.2) | 2,819 | 2,712 | 107 | 3.9 | |
Operating profit | 1,806 | 2,083 | (277) | (13.3) | 1,380 | 1,483 | (103) | (6.9) | |
Functional Solutions | 1,582 | 1,665 | (83) | (5.0) | 1,764 | 1,585 | 178 | 11.2 | |
Medical | 540 | 594 | (53) | (8.9) | 407 | 685 | (277) | (40.4) | |
Apparel | 363 | 563 | (200) | (35.6) | (113) | (146) | 32 | - | |
Life Creation | 246 | 150 | 96 | 64.0 | 228 | 152 | 76 | 50.0 | |
Ordinary profit | 1,838 | 2,272 | (434) | (19.1) | 1,366 | 1,394 | (28) | (2.0) | |
Profit attributable to owners of parent | (1,473) | 1,600 | (3,074) | - | 814 | 1,356 | (542) | (40.0) | |
I-11. Financial Results for FY2025 2Q
(Million of yen)
FY2025 2Q | FY2024 2Q | Change | |
Total Assets | 157,440 | 159,677 | (2,237) |
Equity | 110,816 | 119,074 | (8,258) |
Equity Ratio | 70.4% | 74.6% | (4.2%) |
Interest-bearing debt | 15,727 | 8,960 | 6,767 |
BPS Net Assets per Share (JPY) | 3,410.34 | 3,667.20 | (256.86) |
III-6. Details of Changes in Assets
Difference from the end of the previous period (Billions of yen)
Cash and Deposits
(1.2)
(0.6)
Accounts
(1.0)
Property, Plant and equipment
Decrease of 2.2
0.4
receivable
Inventories
(0.4)
0.5
0.1
Others
159.6
Others
Investment in securities
157.4
End of FY2024 Total assets
< Current assets (3.2) >
< Fixed assets 1.0 >
End of Sept., 2025 Total assets
Ⅰ-13. Cash Flow
Cash Flow
(Million of yen)
FY 2025
2Q
FY 2024
2Q
Change
| |
Operating profit | 3,186 |
Depreciation and amortization | 3,553 |
| |
Purchase of Fixed Assets | (7,906) |
| |
Increase in short-term debt and commercial paper | 7,285 |
Dividend Paid | (6,296) |
Operating Activities | 6,650 | 5,651 | 998 |
Investing Activities | (7,997) | (4,254) | (3,742) |
FCF | (1,347) | 1,397 | (2,744) |
Financing Activities | 554 | 571 | (17) |
Cash and Cash Equivalents | 9,380 | 13,345 | (3,965) |
I-14. Capital Expenditures and Depreciation Expenses
YoY Change at 2Q(Million of yen)
Capital Expenditures | Depreciation | |||||||
FY 2025 | FY 2024 | Change | FY 2025 | FY 2024 | Change | |||
Forecast | 2Q | Full-Year | ||||||
Forecast | 2Q | Full-Year | ||||||
Functional Solutions | 7,500 | 5,063 | 1,784 | 5,716 | 3,100 | 1,434 | 2,803 | 297 |
Medical | 3,300 | 971 | 2,315 | 985 | 800 | 335 | 575 | 225 |
Apparel | 3,500 | 431 | 1,961 | 1,539 | 1,700 | 715 | 1,432 | 268 |
Life Creation | 1,400 | 776 | 842 | 558 | 1,600 | 793 | 1,516 | 84 |
Other | 500 | 146 | 634 | (134) | 600 | 296 | 539 | 61 |
Total | 16,200 | 7,389 | 7,538 | 8,662 | 7,800 | 3,575 | 6,867 | 933 |
Engineering Plastics: Capacity expansion and new plant
Major investment plan
in FY2025
construction
4,000
20
Medical: Capacity expansion and new plant construction 3,000
Apparel: Overseas production facility relocation due to business restructuring
1,700
21
- Business Review for the Second Quarter
Ⅱ-1. Business Review for the Second Quarter
F u n c t i o n a l S o l u t i o n s 1
Position
Plastic filmsIntroduce new environmentally friendly products to the market and promote
the development of recycling factories.
Profit increased
Category
Shrink film domestic
Flexible packaging
Industrial Packaging
OPP film
Shrink film overseas
Main Products
Hybrid styrene shrink film is made by coextrusion of PET and PS.
It has both well shrinkage and shrink characteristics.
Olefin shrink film has a low specific gravity and easy to recycle.
The products have excellent gas barrier and pinhole resistance for food industry.
For semiconductor manufacturing , EV batteries, and wallpaper industry etc.
Excellent anti-fog characteristic for food package.
Shrink films can be supplied world wide. The company has three production site in USA, China, and Vietnam.
Topics
Although the beverage sector has been impacted by declining consumer sentiment and increased final product prices, it has expanded its sales channels, particularly for environmentally conscious products.
Due to rising prices and sluggish domestic consumption, the company launched products that balance functionality and affordability in the general-purpose market to secure new sales channels.
The market remains robust, driven primarily by increased demand for generative AI-related products and steady demand for semiconductor tapes used in expanding data centers.
Focusing on high-value products through production consolidation and
prioritizing profitability.
The price offensive of Chinese products impacts all locations.
US: Mitigating the impact of additional tariffs through cost reduction and price pass-through.
Vietnam: Rebuilding competitiveness through cost reduction. China: Working to improve profitability through cost reduction and
22
Shrink film overseas
Shrink film domestic
reviewing the production system.
OPP
Industrial
Flexible
Ⅱ-1. Business Review for the Second Quarter
Profit increased
Position
F u n c t i o n a l S o l u t i o n s 2
Engineering plastics
To drive business growth, we will strive to expand our share of the OA market while strengthening our non-OA categories, such as semiconductors, medical equipment, and energy.
Category
Main Products
Topics
OA Functional
products
Fluorine thin film tubes for fusing belts/rolls. The intermediate transfer belt has the top share in the global market.
Office multifunction devices and commercial printing
products continue to grow.
Non-OA products
Functional parts used in manufacturing
processes in the industrial market.
Semiconductor products are affected by the market downturn.
A new production line begins operation.
Seamless belt ■Fluorine thin-walled
tubing
Filter support materials
Tear-resistant fluoropolymer tubing
For OA Non-OA
Ⅱ-3. Business Review for the Second Quarter
Position
Medical
Medical
By offering innovative ‘biomaterials × devices’ and steadily expanding sales—especially of absorbable products, we aim to grow into a globally expanding medical device company
Growth & expansion
Category
Bioabsorbable
reinforcement felt
Bone fixation devices
Main products
Suitable for reinforcing sutures and preventing air leakage during surgery.
Effective as a scaffold material for tissue regeneration.
Bioabsorbable bone grafting material with special processing.
Topics
Japan: Steady progress, including additional benefits from new product
launches.
China: Despite intensifying medical insurance cutbacks at large general hospitals, Focusing on penetration into mid-sized hospitals and regional areas. Impacted by the weak yen.
Japan: Stable expansion in acquiring cases in oral surgery.
China: Impacted by purchasing adjustments aimed at reducing high medical costs.
Artificial dermis
Absorbable adhesion barrier sheet
Purchased products
like medical laser
Absorbable artificial skin using collagen.
Absorbable anti-adhesion material consisting of gelatin in film form with an uneven surface.
Medical devices for cosmetics, plastic
surgery, wound care and other products.
Japan: Maintaining current status despite the impact of competitors' new
product entries.
Progress is being made in capturing facilities through strengthened sales activities and pricing strategies. However, intense blocking by competitors is intensifying competition. New factory environmental preparations are underway.
Medical lasers: The hair removal market is showing a recovery trend,
However, new competition is emerging, including the distribution of used
and others
equipment.
Domestic sales
Overseas sales
Business Direction
Ⅱ-4. Business Review for the Second Quarter
A p p a r e l
Restructur ing
Focusing on the value-added category, we are strengthening initiatives such as production and logistics restructuring and improving efficiency in indirect departments to enhance capital efficiency and revitalize the business into a sustainable one
While advancing the prioritization of comprehensive brands,
cost increases since the beginning of the year, resulting in a decline in profits.
Focusing on key brands, consolidating brands, and reducing SKUs.
Centering on e-commerce, the company is accelerating the shift to D2C.
ASEDORON
ASEDORON: Our product line is designed specifically for year-round sweat
management.
KIREILABO: Our line of seamless products, which promotes gentleness for healthy skin, is experiencing strong growth.
LegwearSales have been sluggish due to deteriorating market conditions, and price adjustments are being implemented
Panty hose: Struggled in Q1 due to cautious buying amid unstable weather and rising prices. Implemented partial price revisions starting in NQ2.
Socks: Withdrew from unprofitable categories, which led to a reduction in sales volume. However, profitability is trending upward.
YG "in·T"
SABRINA
Foot Covers
BODYWILD
KIREILABO
Legwear
KIREILABO
Men's Lady's Leg
Business Direction
Ⅱ-5. Business Review for the Second Quarter
L i fe s t yl e Cre at i o ns
Restructuring
- Shopping center business
Strengthen property-specific management focused on investment efficiency, and
improve low-yield assets or shift them to growth areas and new fields
Tsukashin (Amagasaki, Hyogo): In addition to the effects of the renovation, the number of
visitors has significantly increased and steady performance due to efforts to attract customers from nearby.
- Real Estate Leasing Business
Both sales and profits are showing steady growth. Tsukashin shopping center
Sports Club Business
Enhance support for underperforming stores, expand the school business, and develop
differentiated services and new formats aligned with local and store-specific needs
Close unprofitable stores while maintaining sales and improving profitability.
The school business aims to enhance satisfaction and expand sales through membership fee revisions driven
by service enhancements.
The fitness business is strengthening targeted strategies.
School business
Green Business Capture greening demand in development plans and pursue new business
initiatives for CO2 reduction
The tree sales business was affected by a decrease in demand for large-scale projects, including those related to last fiscal year's expo. Construction delays caused by intense heat also impacted the business.
26
Ginkgo trees on Midosuji that Gunze donated last year
- Outlook for FY2025
Ⅲ-1. FY2025 Forecast
※No Revision of forecast (millions of yen)
Item | FY2025 | FY2024 | Change | |||
Forecast | Profit ratio(%) | Results | Profit Ratio(%) | Amount | % | |
Net Sales | 140,000 | 137,117 | 2,883 | 2.1 | ||
Operating profit | 8,500 | 6.1 | 7,921 | 5.8 | 579 | 7.3 |
Operating profit | 8,300 | 5.9 | 8,180 | 6.0 | 120 | 1.5 |
Profit attributable to owners of parent ※ | 2,800 | 2.0 | 6,279 | 4.6 | (3,479) | (55.4%) |
※A decrease in profit is planned due to the expected occurrence of special losses related to structural reforms.
Ⅲ-2. FY2025 Forecast by Segment
※No Revision of forecast (millions of yen)
Net Sales | Operating Profit Bottom: Profit Margin | |||||
FY2025 | FY2024 | Change | FY2025 | FY2024 | Change | |
Functional Solutions | 50,500 | 52,204 | (3.3%) (1,704) | 8,100 16.0% | 7,205 13.8% | 12.4% 895 |
Medical | 15,600 | 12,949 | 20.5% 2,651 | 2,500 16.0% | 2,430 18.8% | 2.9% 70 |
Apparel | 61,400 | 60,782 | 1.0% 618 | 400 0.7% | 753 1.2% | (46.9%) (353) |
Lifestyle Creations | 13,200 | 12,005 | 10.0% 1,195 | 1,200 9.1% | 988 8.3% | 21.5% 212 |
Total | 140,000 | 137,117 | 2.1% 2,883 | 8,500 6.1% | 7,921 5.8% | 7.3% 579 |
Ⅲ-3. Distribution of Earnings to Shareholders
Dividend Per Share and Dividend Payout Ratio
(Unit: JPY)
Forecast
450.0
400.0
350.0
250.5%
300.0%
144.5
50.8%
Dividend payout
ratio
102.8%
ordinary dividend
commemorative divident
Special
dividend
48.8%
46.9%
95.1%
82.9%
56.2%
44.7%
0.0%
5.0
45.2%
47.5%
37.5
37.5
147.0
50.5
69.0
37.5
45.0
55.0
57.5
57.5
70.0
73.5
76.5
250.0%
300.0 200.0%
250.0
200.0
150.0
150.0%
100.0%
100.0
50.0
0.0
※ As of April 1, 2025, a stock split will be conducted at a ratio of 2 shares for each ordinary share Prior periods are also stated on a post-stock split basis
2015/3 2016/3 2017/3 2018/3 2019/3 2020/3 2021/3 2022/3 2023/3 2024/3 2025/3 2026/3※
50.0%
0.0%
